Status of research and development of vaccines for chikungunya

Claire Smalley, Jesse H. Erasmus, Charles B. Chesson, David W.C. Beasley

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Chikungunya virus (CHIKV) is an arthritogenic alphavirus that during the last decade has significantly expanded its geographical range and caused large outbreaks of human disease around the world. Although mortality rates associated with CHIKV outbreaks are low, acute and chronic illnesses caused by CHIKV represent a significant burden of disease largely affecting low and middle income countries. This report summarizes the current status of vaccine development for CHIKV.

Original languageEnglish (US)
Pages (from-to)2976-2981
Number of pages6
Issue number26
StatePublished - Jun 3 2016


  • Alphavirus
  • Chikungunya
  • Emerging disease
  • Polyarthralgia
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Status of research and development of vaccines for chikungunya'. Together they form a unique fingerprint.

Cite this